Global Companion Diagnostic Market 2024 by Company, Regions, Type and Application, Forecast to 2030
According to our (Global Info Research) latest study, the global Companion Diagnostic market size was valued at USD 9075.3 million in 2023 and is forecast to a readjusted size of USD 31360 million by 2030 with a CAGR of 19.4% during review period.
A companion diagnostic device is a special type of invitro medical device that provides information, which is necessary for the effective and safe use of an analogous drug or biological product. Companion diagnostics are developed simultaneously with drugs to help include or exclude a certain group of patients for treatment with a particular drug based on their biological characteristics, which determines patients who respond and those who dont respond to the therapy.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
The Global Info Research report includes an overview of the development of the Companion Diagnostic industry chain, the market status of Oncology (Immunohistochemistry, Molecular Diagnosis), Cardiovascular (Immunohistochemistry, Molecular Diagnosis), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Companion Diagnostic.
Regionally, the report analyzes the Companion Diagnostic markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Companion Diagnostic market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Companion Diagnostic market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Companion Diagnostic industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., Immunohistochemistry, Molecular Diagnosis).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Companion Diagnostic market.
Regional Analysis: The report involves examining the Companion Diagnostic market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Companion Diagnostic market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Companion Diagnostic:
Company Analysis: Report covers individual Companion Diagnostic players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Companion Diagnostic This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Oncology, Cardiovascular).
Technology Analysis: Report covers specific technologies relevant to Companion Diagnostic. It assesses the current state, advancements, and potential future developments in Companion Diagnostic areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Companion Diagnostic market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Companion Diagnostic market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
Chapter 1, to describe Companion Diagnostic product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Companion Diagnostic, with revenue, gross margin and global market share of Companion Diagnostic from 2019 to 2024.
Chapter 3, the Companion Diagnostic competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Companion Diagnostic market forecast, by regions, type and application, with consumption value, from 2025 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Companion Diagnostic.
Chapter 13, to describe Companion Diagnostic research findings and conclusion.
A companion diagnostic device is a special type of invitro medical device that provides information, which is necessary for the effective and safe use of an analogous drug or biological product. Companion diagnostics are developed simultaneously with drugs to help include or exclude a certain group of patients for treatment with a particular drug based on their biological characteristics, which determines patients who respond and those who dont respond to the therapy.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
The Global Info Research report includes an overview of the development of the Companion Diagnostic industry chain, the market status of Oncology (Immunohistochemistry, Molecular Diagnosis), Cardiovascular (Immunohistochemistry, Molecular Diagnosis), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Companion Diagnostic.
Regionally, the report analyzes the Companion Diagnostic markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Companion Diagnostic market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Companion Diagnostic market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Companion Diagnostic industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., Immunohistochemistry, Molecular Diagnosis).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Companion Diagnostic market.
Regional Analysis: The report involves examining the Companion Diagnostic market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Companion Diagnostic market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Companion Diagnostic:
Company Analysis: Report covers individual Companion Diagnostic players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Companion Diagnostic This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Oncology, Cardiovascular).
Technology Analysis: Report covers specific technologies relevant to Companion Diagnostic. It assesses the current state, advancements, and potential future developments in Companion Diagnostic areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Companion Diagnostic market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Companion Diagnostic market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
- Immunohistochemistry
- Molecular Diagnosis
- Oncology
- Cardiovascular
- Central Nervous System
- Virology
- Others
- Roche Holdings
- Abbott Laboratories
- Thermo Fisher Scientific
- Agilent Technologies
- Merck
- Agendia
- Qiagen
- Myriad Genetics
- Advanced Cell Diagnostics
- Danaher
- Illumina, Inc
- North America (United States, Canada, and Mexico)
- Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
- South America (Brazil, Argentina and Rest of South America)
- Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
Chapter 1, to describe Companion Diagnostic product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Companion Diagnostic, with revenue, gross margin and global market share of Companion Diagnostic from 2019 to 2024.
Chapter 3, the Companion Diagnostic competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Companion Diagnostic market forecast, by regions, type and application, with consumption value, from 2025 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Companion Diagnostic.
Chapter 13, to describe Companion Diagnostic research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope of Companion Diagnostic
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Companion Diagnostic by Type
1.3.1 Overview: Global Companion Diagnostic Market Size by Type: 2019 Versus 2023 Versus 2030
1.3.2 Global Companion Diagnostic Consumption Value Market Share by Type in 2023
1.3.3 Immunohistochemistry
1.3.4 Molecular Diagnosis
1.4 Global Companion Diagnostic Market by Application
1.4.1 Overview: Global Companion Diagnostic Market Size by Application: 2019 Versus 2023 Versus 2030
1.4.2 Oncology
1.4.3 Cardiovascular
1.4.4 Central Nervous System
1.4.5 Virology
1.4.6 Others
1.5 Global Companion Diagnostic Market Size & Forecast
1.6 Global Companion Diagnostic Market Size and Forecast by Region
1.6.1 Global Companion Diagnostic Market Size by Region: 2019 VS 2023 VS 2030
1.6.2 Global Companion Diagnostic Market Size by Region, (2019-2030)
1.6.3 North America Companion Diagnostic Market Size and Prospect (2019-2030)
1.6.4 Europe Companion Diagnostic Market Size and Prospect (2019-2030)
1.6.5 Asia-Pacific Companion Diagnostic Market Size and Prospect (2019-2030)
1.6.6 South America Companion Diagnostic Market Size and Prospect (2019-2030)
1.6.7 Middle East and Africa Companion Diagnostic Market Size and Prospect (2019-2030)
2 COMPANY PROFILES
2.1 Roche Holdings
2.1.1 Roche Holdings Details
2.1.2 Roche Holdings Major Business
2.1.3 Roche Holdings Companion Diagnostic Product and Solutions
2.1.4 Roche Holdings Companion Diagnostic Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 Roche Holdings Recent Developments and Future Plans
2.2 Abbott Laboratories
2.2.1 Abbott Laboratories Details
2.2.2 Abbott Laboratories Major Business
2.2.3 Abbott Laboratories Companion Diagnostic Product and Solutions
2.2.4 Abbott Laboratories Companion Diagnostic Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 Abbott Laboratories Recent Developments and Future Plans
2.3 Thermo Fisher Scientific
2.3.1 Thermo Fisher Scientific Details
2.3.2 Thermo Fisher Scientific Major Business
2.3.3 Thermo Fisher Scientific Companion Diagnostic Product and Solutions
2.3.4 Thermo Fisher Scientific Companion Diagnostic Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Thermo Fisher Scientific Recent Developments and Future Plans
2.4 Agilent Technologies
2.4.1 Agilent Technologies Details
2.4.2 Agilent Technologies Major Business
2.4.3 Agilent Technologies Companion Diagnostic Product and Solutions
2.4.4 Agilent Technologies Companion Diagnostic Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 Agilent Technologies Recent Developments and Future Plans
2.5 Merck
2.5.1 Merck Details
2.5.2 Merck Major Business
2.5.3 Merck Companion Diagnostic Product and Solutions
2.5.4 Merck Companion Diagnostic Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 Merck Recent Developments and Future Plans
2.6 Agendia
2.6.1 Agendia Details
2.6.2 Agendia Major Business
2.6.3 Agendia Companion Diagnostic Product and Solutions
2.6.4 Agendia Companion Diagnostic Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 Agendia Recent Developments and Future Plans
2.7 Qiagen
2.7.1 Qiagen Details
2.7.2 Qiagen Major Business
2.7.3 Qiagen Companion Diagnostic Product and Solutions
2.7.4 Qiagen Companion Diagnostic Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 Qiagen Recent Developments and Future Plans
2.8 Myriad Genetics
2.8.1 Myriad Genetics Details
2.8.2 Myriad Genetics Major Business
2.8.3 Myriad Genetics Companion Diagnostic Product and Solutions
2.8.4 Myriad Genetics Companion Diagnostic Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 Myriad Genetics Recent Developments and Future Plans
2.9 Advanced Cell Diagnostics
2.9.1 Advanced Cell Diagnostics Details
2.9.2 Advanced Cell Diagnostics Major Business
2.9.3 Advanced Cell Diagnostics Companion Diagnostic Product and Solutions
2.9.4 Advanced Cell Diagnostics Companion Diagnostic Revenue, Gross Margin and Market Share (2019-2024)
2.9.5 Advanced Cell Diagnostics Recent Developments and Future Plans
2.10 Danaher
2.10.1 Danaher Details
2.10.2 Danaher Major Business
2.10.3 Danaher Companion Diagnostic Product and Solutions
2.10.4 Danaher Companion Diagnostic Revenue, Gross Margin and Market Share (2019-2024)
2.10.5 Danaher Recent Developments and Future Plans
2.11 Illumina, Inc
2.11.1 Illumina, Inc Details
2.11.2 Illumina, Inc Major Business
2.11.3 Illumina, Inc Companion Diagnostic Product and Solutions
2.11.4 Illumina, Inc Companion Diagnostic Revenue, Gross Margin and Market Share (2019-2024)
2.11.5 Illumina, Inc Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Companion Diagnostic Revenue and Share by Players (2019-2024)
3.2 Market Share Analysis (2023)
3.2.1 Market Share of Companion Diagnostic by Company Revenue
3.2.2 Top 3 Companion Diagnostic Players Market Share in 2023
3.2.3 Top 6 Companion Diagnostic Players Market Share in 2023
3.3 Companion Diagnostic Market: Overall Company Footprint Analysis
3.3.1 Companion Diagnostic Market: Region Footprint
3.3.2 Companion Diagnostic Market: Company Product Type Footprint
3.3.3 Companion Diagnostic Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Companion Diagnostic Consumption Value and Market Share by Type (2019-2024)
4.2 Global Companion Diagnostic Market Forecast by Type (2025-2030)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Companion Diagnostic Consumption Value Market Share by Application (2019-2024)
5.2 Global Companion Diagnostic Market Forecast by Application (2025-2030)
6 NORTH AMERICA
6.1 North America Companion Diagnostic Consumption Value by Type (2019-2030)
6.2 North America Companion Diagnostic Consumption Value by Application (2019-2030)
6.3 North America Companion Diagnostic Market Size by Country
6.3.1 North America Companion Diagnostic Consumption Value by Country (2019-2030)
6.3.2 United States Companion Diagnostic Market Size and Forecast (2019-2030)
6.3.3 Canada Companion Diagnostic Market Size and Forecast (2019-2030)
6.3.4 Mexico Companion Diagnostic Market Size and Forecast (2019-2030)
7 EUROPE
7.1 Europe Companion Diagnostic Consumption Value by Type (2019-2030)
7.2 Europe Companion Diagnostic Consumption Value by Application (2019-2030)
7.3 Europe Companion Diagnostic Market Size by Country
7.3.1 Europe Companion Diagnostic Consumption Value by Country (2019-2030)
7.3.2 Germany Companion Diagnostic Market Size and Forecast (2019-2030)
7.3.3 France Companion Diagnostic Market Size and Forecast (2019-2030)
7.3.4 United Kingdom Companion Diagnostic Market Size and Forecast (2019-2030)
7.3.5 Russia Companion Diagnostic Market Size and Forecast (2019-2030)
7.3.6 Italy Companion Diagnostic Market Size and Forecast (2019-2030)
8 ASIA-PACIFIC
8.1 Asia-Pacific Companion Diagnostic Consumption Value by Type (2019-2030)
8.2 Asia-Pacific Companion Diagnostic Consumption Value by Application (2019-2030)
8.3 Asia-Pacific Companion Diagnostic Market Size by Region
8.3.1 Asia-Pacific Companion Diagnostic Consumption Value by Region (2019-2030)
8.3.2 China Companion Diagnostic Market Size and Forecast (2019-2030)
8.3.3 Japan Companion Diagnostic Market Size and Forecast (2019-2030)
8.3.4 South Korea Companion Diagnostic Market Size and Forecast (2019-2030)
8.3.5 India Companion Diagnostic Market Size and Forecast (2019-2030)
8.3.6 Southeast Asia Companion Diagnostic Market Size and Forecast (2019-2030)
8.3.7 Australia Companion Diagnostic Market Size and Forecast (2019-2030)
9 SOUTH AMERICA
9.1 South America Companion Diagnostic Consumption Value by Type (2019-2030)
9.2 South America Companion Diagnostic Consumption Value by Application (2019-2030)
9.3 South America Companion Diagnostic Market Size by Country
9.3.1 South America Companion Diagnostic Consumption Value by Country (2019-2030)
9.3.2 Brazil Companion Diagnostic Market Size and Forecast (2019-2030)
9.3.3 Argentina Companion Diagnostic Market Size and Forecast (2019-2030)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Companion Diagnostic Consumption Value by Type (2019-2030)
10.2 Middle East & Africa Companion Diagnostic Consumption Value by Application (2019-2030)
10.3 Middle East & Africa Companion Diagnostic Market Size by Country
10.3.1 Middle East & Africa Companion Diagnostic Consumption Value by Country (2019-2030)
10.3.2 Turkey Companion Diagnostic Market Size and Forecast (2019-2030)
10.3.3 Saudi Arabia Companion Diagnostic Market Size and Forecast (2019-2030)
10.3.4 UAE Companion Diagnostic Market Size and Forecast (2019-2030)
11 MARKET DYNAMICS
11.1 Companion Diagnostic Market Drivers
11.2 Companion Diagnostic Market Restraints
11.3 Companion Diagnostic Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 INDUSTRY CHAIN ANALYSIS
12.1 Companion Diagnostic Industry Chain
12.2 Companion Diagnostic Upstream Analysis
12.3 Companion Diagnostic Midstream Analysis
12.4 Companion Diagnostic Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
1.1 Product Overview and Scope of Companion Diagnostic
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Companion Diagnostic by Type
1.3.1 Overview: Global Companion Diagnostic Market Size by Type: 2019 Versus 2023 Versus 2030
1.3.2 Global Companion Diagnostic Consumption Value Market Share by Type in 2023
1.3.3 Immunohistochemistry
1.3.4 Molecular Diagnosis
1.4 Global Companion Diagnostic Market by Application
1.4.1 Overview: Global Companion Diagnostic Market Size by Application: 2019 Versus 2023 Versus 2030
1.4.2 Oncology
1.4.3 Cardiovascular
1.4.4 Central Nervous System
1.4.5 Virology
1.4.6 Others
1.5 Global Companion Diagnostic Market Size & Forecast
1.6 Global Companion Diagnostic Market Size and Forecast by Region
1.6.1 Global Companion Diagnostic Market Size by Region: 2019 VS 2023 VS 2030
1.6.2 Global Companion Diagnostic Market Size by Region, (2019-2030)
1.6.3 North America Companion Diagnostic Market Size and Prospect (2019-2030)
1.6.4 Europe Companion Diagnostic Market Size and Prospect (2019-2030)
1.6.5 Asia-Pacific Companion Diagnostic Market Size and Prospect (2019-2030)
1.6.6 South America Companion Diagnostic Market Size and Prospect (2019-2030)
1.6.7 Middle East and Africa Companion Diagnostic Market Size and Prospect (2019-2030)
2 COMPANY PROFILES
2.1 Roche Holdings
2.1.1 Roche Holdings Details
2.1.2 Roche Holdings Major Business
2.1.3 Roche Holdings Companion Diagnostic Product and Solutions
2.1.4 Roche Holdings Companion Diagnostic Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 Roche Holdings Recent Developments and Future Plans
2.2 Abbott Laboratories
2.2.1 Abbott Laboratories Details
2.2.2 Abbott Laboratories Major Business
2.2.3 Abbott Laboratories Companion Diagnostic Product and Solutions
2.2.4 Abbott Laboratories Companion Diagnostic Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 Abbott Laboratories Recent Developments and Future Plans
2.3 Thermo Fisher Scientific
2.3.1 Thermo Fisher Scientific Details
2.3.2 Thermo Fisher Scientific Major Business
2.3.3 Thermo Fisher Scientific Companion Diagnostic Product and Solutions
2.3.4 Thermo Fisher Scientific Companion Diagnostic Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Thermo Fisher Scientific Recent Developments and Future Plans
2.4 Agilent Technologies
2.4.1 Agilent Technologies Details
2.4.2 Agilent Technologies Major Business
2.4.3 Agilent Technologies Companion Diagnostic Product and Solutions
2.4.4 Agilent Technologies Companion Diagnostic Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 Agilent Technologies Recent Developments and Future Plans
2.5 Merck
2.5.1 Merck Details
2.5.2 Merck Major Business
2.5.3 Merck Companion Diagnostic Product and Solutions
2.5.4 Merck Companion Diagnostic Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 Merck Recent Developments and Future Plans
2.6 Agendia
2.6.1 Agendia Details
2.6.2 Agendia Major Business
2.6.3 Agendia Companion Diagnostic Product and Solutions
2.6.4 Agendia Companion Diagnostic Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 Agendia Recent Developments and Future Plans
2.7 Qiagen
2.7.1 Qiagen Details
2.7.2 Qiagen Major Business
2.7.3 Qiagen Companion Diagnostic Product and Solutions
2.7.4 Qiagen Companion Diagnostic Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 Qiagen Recent Developments and Future Plans
2.8 Myriad Genetics
2.8.1 Myriad Genetics Details
2.8.2 Myriad Genetics Major Business
2.8.3 Myriad Genetics Companion Diagnostic Product and Solutions
2.8.4 Myriad Genetics Companion Diagnostic Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 Myriad Genetics Recent Developments and Future Plans
2.9 Advanced Cell Diagnostics
2.9.1 Advanced Cell Diagnostics Details
2.9.2 Advanced Cell Diagnostics Major Business
2.9.3 Advanced Cell Diagnostics Companion Diagnostic Product and Solutions
2.9.4 Advanced Cell Diagnostics Companion Diagnostic Revenue, Gross Margin and Market Share (2019-2024)
2.9.5 Advanced Cell Diagnostics Recent Developments and Future Plans
2.10 Danaher
2.10.1 Danaher Details
2.10.2 Danaher Major Business
2.10.3 Danaher Companion Diagnostic Product and Solutions
2.10.4 Danaher Companion Diagnostic Revenue, Gross Margin and Market Share (2019-2024)
2.10.5 Danaher Recent Developments and Future Plans
2.11 Illumina, Inc
2.11.1 Illumina, Inc Details
2.11.2 Illumina, Inc Major Business
2.11.3 Illumina, Inc Companion Diagnostic Product and Solutions
2.11.4 Illumina, Inc Companion Diagnostic Revenue, Gross Margin and Market Share (2019-2024)
2.11.5 Illumina, Inc Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Companion Diagnostic Revenue and Share by Players (2019-2024)
3.2 Market Share Analysis (2023)
3.2.1 Market Share of Companion Diagnostic by Company Revenue
3.2.2 Top 3 Companion Diagnostic Players Market Share in 2023
3.2.3 Top 6 Companion Diagnostic Players Market Share in 2023
3.3 Companion Diagnostic Market: Overall Company Footprint Analysis
3.3.1 Companion Diagnostic Market: Region Footprint
3.3.2 Companion Diagnostic Market: Company Product Type Footprint
3.3.3 Companion Diagnostic Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Companion Diagnostic Consumption Value and Market Share by Type (2019-2024)
4.2 Global Companion Diagnostic Market Forecast by Type (2025-2030)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Companion Diagnostic Consumption Value Market Share by Application (2019-2024)
5.2 Global Companion Diagnostic Market Forecast by Application (2025-2030)
6 NORTH AMERICA
6.1 North America Companion Diagnostic Consumption Value by Type (2019-2030)
6.2 North America Companion Diagnostic Consumption Value by Application (2019-2030)
6.3 North America Companion Diagnostic Market Size by Country
6.3.1 North America Companion Diagnostic Consumption Value by Country (2019-2030)
6.3.2 United States Companion Diagnostic Market Size and Forecast (2019-2030)
6.3.3 Canada Companion Diagnostic Market Size and Forecast (2019-2030)
6.3.4 Mexico Companion Diagnostic Market Size and Forecast (2019-2030)
7 EUROPE
7.1 Europe Companion Diagnostic Consumption Value by Type (2019-2030)
7.2 Europe Companion Diagnostic Consumption Value by Application (2019-2030)
7.3 Europe Companion Diagnostic Market Size by Country
7.3.1 Europe Companion Diagnostic Consumption Value by Country (2019-2030)
7.3.2 Germany Companion Diagnostic Market Size and Forecast (2019-2030)
7.3.3 France Companion Diagnostic Market Size and Forecast (2019-2030)
7.3.4 United Kingdom Companion Diagnostic Market Size and Forecast (2019-2030)
7.3.5 Russia Companion Diagnostic Market Size and Forecast (2019-2030)
7.3.6 Italy Companion Diagnostic Market Size and Forecast (2019-2030)
8 ASIA-PACIFIC
8.1 Asia-Pacific Companion Diagnostic Consumption Value by Type (2019-2030)
8.2 Asia-Pacific Companion Diagnostic Consumption Value by Application (2019-2030)
8.3 Asia-Pacific Companion Diagnostic Market Size by Region
8.3.1 Asia-Pacific Companion Diagnostic Consumption Value by Region (2019-2030)
8.3.2 China Companion Diagnostic Market Size and Forecast (2019-2030)
8.3.3 Japan Companion Diagnostic Market Size and Forecast (2019-2030)
8.3.4 South Korea Companion Diagnostic Market Size and Forecast (2019-2030)
8.3.5 India Companion Diagnostic Market Size and Forecast (2019-2030)
8.3.6 Southeast Asia Companion Diagnostic Market Size and Forecast (2019-2030)
8.3.7 Australia Companion Diagnostic Market Size and Forecast (2019-2030)
9 SOUTH AMERICA
9.1 South America Companion Diagnostic Consumption Value by Type (2019-2030)
9.2 South America Companion Diagnostic Consumption Value by Application (2019-2030)
9.3 South America Companion Diagnostic Market Size by Country
9.3.1 South America Companion Diagnostic Consumption Value by Country (2019-2030)
9.3.2 Brazil Companion Diagnostic Market Size and Forecast (2019-2030)
9.3.3 Argentina Companion Diagnostic Market Size and Forecast (2019-2030)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Companion Diagnostic Consumption Value by Type (2019-2030)
10.2 Middle East & Africa Companion Diagnostic Consumption Value by Application (2019-2030)
10.3 Middle East & Africa Companion Diagnostic Market Size by Country
10.3.1 Middle East & Africa Companion Diagnostic Consumption Value by Country (2019-2030)
10.3.2 Turkey Companion Diagnostic Market Size and Forecast (2019-2030)
10.3.3 Saudi Arabia Companion Diagnostic Market Size and Forecast (2019-2030)
10.3.4 UAE Companion Diagnostic Market Size and Forecast (2019-2030)
11 MARKET DYNAMICS
11.1 Companion Diagnostic Market Drivers
11.2 Companion Diagnostic Market Restraints
11.3 Companion Diagnostic Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 INDUSTRY CHAIN ANALYSIS
12.1 Companion Diagnostic Industry Chain
12.2 Companion Diagnostic Upstream Analysis
12.3 Companion Diagnostic Midstream Analysis
12.4 Companion Diagnostic Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
LIST OF TABLES
Table 1. Global Companion Diagnostic Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global Companion Diagnostic Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. Global Companion Diagnostic Consumption Value by Region (2019-2024) & (USD Million)
Table 4. Global Companion Diagnostic Consumption Value by Region (2025-2030) & (USD Million)
Table 5. Roche Holdings Company Information, Head Office, and Major Competitors
Table 6. Roche Holdings Major Business
Table 7. Roche Holdings Companion Diagnostic Product and Solutions
Table 8. Roche Holdings Companion Diagnostic Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 9. Roche Holdings Recent Developments and Future Plans
Table 10. Abbott Laboratories Company Information, Head Office, and Major Competitors
Table 11. Abbott Laboratories Major Business
Table 12. Abbott Laboratories Companion Diagnostic Product and Solutions
Table 13. Abbott Laboratories Companion Diagnostic Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 14. Abbott Laboratories Recent Developments and Future Plans
Table 15. Thermo Fisher Scientific Company Information, Head Office, and Major Competitors
Table 16. Thermo Fisher Scientific Major Business
Table 17. Thermo Fisher Scientific Companion Diagnostic Product and Solutions
Table 18. Thermo Fisher Scientific Companion Diagnostic Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 19. Thermo Fisher Scientific Recent Developments and Future Plans
Table 20. Agilent Technologies Company Information, Head Office, and Major Competitors
Table 21. Agilent Technologies Major Business
Table 22. Agilent Technologies Companion Diagnostic Product and Solutions
Table 23. Agilent Technologies Companion Diagnostic Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 24. Agilent Technologies Recent Developments and Future Plans
Table 25. Merck Company Information, Head Office, and Major Competitors
Table 26. Merck Major Business
Table 27. Merck Companion Diagnostic Product and Solutions
Table 28. Merck Companion Diagnostic Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 29. Merck Recent Developments and Future Plans
Table 30. Agendia Company Information, Head Office, and Major Competitors
Table 31. Agendia Major Business
Table 32. Agendia Companion Diagnostic Product and Solutions
Table 33. Agendia Companion Diagnostic Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 34. Agendia Recent Developments and Future Plans
Table 35. Qiagen Company Information, Head Office, and Major Competitors
Table 36. Qiagen Major Business
Table 37. Qiagen Companion Diagnostic Product and Solutions
Table 38. Qiagen Companion Diagnostic Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 39. Qiagen Recent Developments and Future Plans
Table 40. Myriad Genetics Company Information, Head Office, and Major Competitors
Table 41. Myriad Genetics Major Business
Table 42. Myriad Genetics Companion Diagnostic Product and Solutions
Table 43. Myriad Genetics Companion Diagnostic Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 44. Myriad Genetics Recent Developments and Future Plans
Table 45. Advanced Cell Diagnostics Company Information, Head Office, and Major Competitors
Table 46. Advanced Cell Diagnostics Major Business
Table 47. Advanced Cell Diagnostics Companion Diagnostic Product and Solutions
Table 48. Advanced Cell Diagnostics Companion Diagnostic Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 49. Advanced Cell Diagnostics Recent Developments and Future Plans
Table 50. Danaher Company Information, Head Office, and Major Competitors
Table 51. Danaher Major Business
Table 52. Danaher Companion Diagnostic Product and Solutions
Table 53. Danaher Companion Diagnostic Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 54. Danaher Recent Developments and Future Plans
Table 55. Illumina, Inc Company Information, Head Office, and Major Competitors
Table 56. Illumina, Inc Major Business
Table 57. Illumina, Inc Companion Diagnostic Product and Solutions
Table 58. Illumina, Inc Companion Diagnostic Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 59. Illumina, Inc Recent Developments and Future Plans
Table 60. Global Companion Diagnostic Revenue (USD Million) by Players (2019-2024)
Table 61. Global Companion Diagnostic Revenue Share by Players (2019-2024)
Table 62. Breakdown of Companion Diagnostic by Company Type (Tier 1, Tier 2, and Tier 3)
Table 63. Market Position of Players in Companion Diagnostic, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2023
Table 64. Head Office of Key Companion Diagnostic Players
Table 65. Companion Diagnostic Market: Company Product Type Footprint
Table 66. Companion Diagnostic Market: Company Product Application Footprint
Table 67. Companion Diagnostic New Market Entrants and Barriers to Market Entry
Table 68. Companion Diagnostic Mergers, Acquisition, Agreements, and Collaborations
Table 69. Global Companion Diagnostic Consumption Value (USD Million) by Type (2019-2024)
Table 70. Global Companion Diagnostic Consumption Value Share by Type (2019-2024)
Table 71. Global Companion Diagnostic Consumption Value Forecast by Type (2025-2030)
Table 72. Global Companion Diagnostic Consumption Value by Application (2019-2024)
Table 73. Global Companion Diagnostic Consumption Value Forecast by Application (2025-2030)
Table 74. North America Companion Diagnostic Consumption Value by Type (2019-2024) & (USD Million)
Table 75. North America Companion Diagnostic Consumption Value by Type (2025-2030) & (USD Million)
Table 76. North America Companion Diagnostic Consumption Value by Application (2019-2024) & (USD Million)
Table 77. North America Companion Diagnostic Consumption Value by Application (2025-2030) & (USD Million)
Table 78. North America Companion Diagnostic Consumption Value by Country (2019-2024) & (USD Million)
Table 79. North America Companion Diagnostic Consumption Value by Country (2025-2030) & (USD Million)
Table 80. Europe Companion Diagnostic Consumption Value by Type (2019-2024) & (USD Million)
Table 81. Europe Companion Diagnostic Consumption Value by Type (2025-2030) & (USD Million)
Table 82. Europe Companion Diagnostic Consumption Value by Application (2019-2024) & (USD Million)
Table 83. Europe Companion Diagnostic Consumption Value by Application (2025-2030) & (USD Million)
Table 84. Europe Companion Diagnostic Consumption Value by Country (2019-2024) & (USD Million)
Table 85. Europe Companion Diagnostic Consumption Value by Country (2025-2030) & (USD Million)
Table 86. Asia-Pacific Companion Diagnostic Consumption Value by Type (2019-2024) & (USD Million)
Table 87. Asia-Pacific Companion Diagnostic Consumption Value by Type (2025-2030) & (USD Million)
Table 88. Asia-Pacific Companion Diagnostic Consumption Value by Application (2019-2024) & (USD Million)
Table 89. Asia-Pacific Companion Diagnostic Consumption Value by Application (2025-2030) & (USD Million)
Table 90. Asia-Pacific Companion Diagnostic Consumption Value by Region (2019-2024) & (USD Million)
Table 91. Asia-Pacific Companion Diagnostic Consumption Value by Region (2025-2030) & (USD Million)
Table 92. South America Companion Diagnostic Consumption Value by Type (2019-2024) & (USD Million)
Table 93. South America Companion Diagnostic Consumption Value by Type (2025-2030) & (USD Million)
Table 94. South America Companion Diagnostic Consumption Value by Application (2019-2024) & (USD Million)
Table 95. South America Companion Diagnostic Consumption Value by Application (2025-2030) & (USD Million)
Table 96. South America Companion Diagnostic Consumption Value by Country (2019-2024) & (USD Million)
Table 97. South America Companion Diagnostic Consumption Value by Country (2025-2030) & (USD Million)
Table 98. Middle East & Africa Companion Diagnostic Consumption Value by Type (2019-2024) & (USD Million)
Table 99. Middle East & Africa Companion Diagnostic Consumption Value by Type (2025-2030) & (USD Million)
Table 100. Middle East & Africa Companion Diagnostic Consumption Value by Application (2019-2024) & (USD Million)
Table 101. Middle East & Africa Companion Diagnostic Consumption Value by Application (2025-2030) & (USD Million)
Table 102. Middle East & Africa Companion Diagnostic Consumption Value by Country (2019-2024) & (USD Million)
Table 103. Middle East & Africa Companion Diagnostic Consumption Value by Country (2025-2030) & (USD Million)
Table 104. Companion Diagnostic Raw Material
Table 105. Key Suppliers of Companion Diagnostic Raw Materials
Table 1. Global Companion Diagnostic Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global Companion Diagnostic Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. Global Companion Diagnostic Consumption Value by Region (2019-2024) & (USD Million)
Table 4. Global Companion Diagnostic Consumption Value by Region (2025-2030) & (USD Million)
Table 5. Roche Holdings Company Information, Head Office, and Major Competitors
Table 6. Roche Holdings Major Business
Table 7. Roche Holdings Companion Diagnostic Product and Solutions
Table 8. Roche Holdings Companion Diagnostic Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 9. Roche Holdings Recent Developments and Future Plans
Table 10. Abbott Laboratories Company Information, Head Office, and Major Competitors
Table 11. Abbott Laboratories Major Business
Table 12. Abbott Laboratories Companion Diagnostic Product and Solutions
Table 13. Abbott Laboratories Companion Diagnostic Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 14. Abbott Laboratories Recent Developments and Future Plans
Table 15. Thermo Fisher Scientific Company Information, Head Office, and Major Competitors
Table 16. Thermo Fisher Scientific Major Business
Table 17. Thermo Fisher Scientific Companion Diagnostic Product and Solutions
Table 18. Thermo Fisher Scientific Companion Diagnostic Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 19. Thermo Fisher Scientific Recent Developments and Future Plans
Table 20. Agilent Technologies Company Information, Head Office, and Major Competitors
Table 21. Agilent Technologies Major Business
Table 22. Agilent Technologies Companion Diagnostic Product and Solutions
Table 23. Agilent Technologies Companion Diagnostic Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 24. Agilent Technologies Recent Developments and Future Plans
Table 25. Merck Company Information, Head Office, and Major Competitors
Table 26. Merck Major Business
Table 27. Merck Companion Diagnostic Product and Solutions
Table 28. Merck Companion Diagnostic Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 29. Merck Recent Developments and Future Plans
Table 30. Agendia Company Information, Head Office, and Major Competitors
Table 31. Agendia Major Business
Table 32. Agendia Companion Diagnostic Product and Solutions
Table 33. Agendia Companion Diagnostic Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 34. Agendia Recent Developments and Future Plans
Table 35. Qiagen Company Information, Head Office, and Major Competitors
Table 36. Qiagen Major Business
Table 37. Qiagen Companion Diagnostic Product and Solutions
Table 38. Qiagen Companion Diagnostic Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 39. Qiagen Recent Developments and Future Plans
Table 40. Myriad Genetics Company Information, Head Office, and Major Competitors
Table 41. Myriad Genetics Major Business
Table 42. Myriad Genetics Companion Diagnostic Product and Solutions
Table 43. Myriad Genetics Companion Diagnostic Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 44. Myriad Genetics Recent Developments and Future Plans
Table 45. Advanced Cell Diagnostics Company Information, Head Office, and Major Competitors
Table 46. Advanced Cell Diagnostics Major Business
Table 47. Advanced Cell Diagnostics Companion Diagnostic Product and Solutions
Table 48. Advanced Cell Diagnostics Companion Diagnostic Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 49. Advanced Cell Diagnostics Recent Developments and Future Plans
Table 50. Danaher Company Information, Head Office, and Major Competitors
Table 51. Danaher Major Business
Table 52. Danaher Companion Diagnostic Product and Solutions
Table 53. Danaher Companion Diagnostic Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 54. Danaher Recent Developments and Future Plans
Table 55. Illumina, Inc Company Information, Head Office, and Major Competitors
Table 56. Illumina, Inc Major Business
Table 57. Illumina, Inc Companion Diagnostic Product and Solutions
Table 58. Illumina, Inc Companion Diagnostic Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 59. Illumina, Inc Recent Developments and Future Plans
Table 60. Global Companion Diagnostic Revenue (USD Million) by Players (2019-2024)
Table 61. Global Companion Diagnostic Revenue Share by Players (2019-2024)
Table 62. Breakdown of Companion Diagnostic by Company Type (Tier 1, Tier 2, and Tier 3)
Table 63. Market Position of Players in Companion Diagnostic, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2023
Table 64. Head Office of Key Companion Diagnostic Players
Table 65. Companion Diagnostic Market: Company Product Type Footprint
Table 66. Companion Diagnostic Market: Company Product Application Footprint
Table 67. Companion Diagnostic New Market Entrants and Barriers to Market Entry
Table 68. Companion Diagnostic Mergers, Acquisition, Agreements, and Collaborations
Table 69. Global Companion Diagnostic Consumption Value (USD Million) by Type (2019-2024)
Table 70. Global Companion Diagnostic Consumption Value Share by Type (2019-2024)
Table 71. Global Companion Diagnostic Consumption Value Forecast by Type (2025-2030)
Table 72. Global Companion Diagnostic Consumption Value by Application (2019-2024)
Table 73. Global Companion Diagnostic Consumption Value Forecast by Application (2025-2030)
Table 74. North America Companion Diagnostic Consumption Value by Type (2019-2024) & (USD Million)
Table 75. North America Companion Diagnostic Consumption Value by Type (2025-2030) & (USD Million)
Table 76. North America Companion Diagnostic Consumption Value by Application (2019-2024) & (USD Million)
Table 77. North America Companion Diagnostic Consumption Value by Application (2025-2030) & (USD Million)
Table 78. North America Companion Diagnostic Consumption Value by Country (2019-2024) & (USD Million)
Table 79. North America Companion Diagnostic Consumption Value by Country (2025-2030) & (USD Million)
Table 80. Europe Companion Diagnostic Consumption Value by Type (2019-2024) & (USD Million)
Table 81. Europe Companion Diagnostic Consumption Value by Type (2025-2030) & (USD Million)
Table 82. Europe Companion Diagnostic Consumption Value by Application (2019-2024) & (USD Million)
Table 83. Europe Companion Diagnostic Consumption Value by Application (2025-2030) & (USD Million)
Table 84. Europe Companion Diagnostic Consumption Value by Country (2019-2024) & (USD Million)
Table 85. Europe Companion Diagnostic Consumption Value by Country (2025-2030) & (USD Million)
Table 86. Asia-Pacific Companion Diagnostic Consumption Value by Type (2019-2024) & (USD Million)
Table 87. Asia-Pacific Companion Diagnostic Consumption Value by Type (2025-2030) & (USD Million)
Table 88. Asia-Pacific Companion Diagnostic Consumption Value by Application (2019-2024) & (USD Million)
Table 89. Asia-Pacific Companion Diagnostic Consumption Value by Application (2025-2030) & (USD Million)
Table 90. Asia-Pacific Companion Diagnostic Consumption Value by Region (2019-2024) & (USD Million)
Table 91. Asia-Pacific Companion Diagnostic Consumption Value by Region (2025-2030) & (USD Million)
Table 92. South America Companion Diagnostic Consumption Value by Type (2019-2024) & (USD Million)
Table 93. South America Companion Diagnostic Consumption Value by Type (2025-2030) & (USD Million)
Table 94. South America Companion Diagnostic Consumption Value by Application (2019-2024) & (USD Million)
Table 95. South America Companion Diagnostic Consumption Value by Application (2025-2030) & (USD Million)
Table 96. South America Companion Diagnostic Consumption Value by Country (2019-2024) & (USD Million)
Table 97. South America Companion Diagnostic Consumption Value by Country (2025-2030) & (USD Million)
Table 98. Middle East & Africa Companion Diagnostic Consumption Value by Type (2019-2024) & (USD Million)
Table 99. Middle East & Africa Companion Diagnostic Consumption Value by Type (2025-2030) & (USD Million)
Table 100. Middle East & Africa Companion Diagnostic Consumption Value by Application (2019-2024) & (USD Million)
Table 101. Middle East & Africa Companion Diagnostic Consumption Value by Application (2025-2030) & (USD Million)
Table 102. Middle East & Africa Companion Diagnostic Consumption Value by Country (2019-2024) & (USD Million)
Table 103. Middle East & Africa Companion Diagnostic Consumption Value by Country (2025-2030) & (USD Million)
Table 104. Companion Diagnostic Raw Material
Table 105. Key Suppliers of Companion Diagnostic Raw Materials
LIST OF FIGURES
Figure 1. Companion Diagnostic Picture
Figure 2. Global Companion Diagnostic Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Companion Diagnostic Consumption Value Market Share by Type in 2023
Figure 4. Immunohistochemistry
Figure 5. Molecular Diagnosis
Figure 6. Global Companion Diagnostic Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 7. Companion Diagnostic Consumption Value Market Share by Application in 2023
Figure 8. Oncology Picture
Figure 9. Cardiovascular Picture
Figure 10. Central Nervous System Picture
Figure 11. Virology Picture
Figure 12. Others Picture
Figure 13. Global Companion Diagnostic Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 14. Global Companion Diagnostic Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 15. Global Market Companion Diagnostic Consumption Value (USD Million) Comparison by Region (2019 & 2023 & 2030)
Figure 16. Global Companion Diagnostic Consumption Value Market Share by Region (2019-2030)
Figure 17. Global Companion Diagnostic Consumption Value Market Share by Region in 2023
Figure 18. North America Companion Diagnostic Consumption Value (2019-2030) & (USD Million)
Figure 19. Europe Companion Diagnostic Consumption Value (2019-2030) & (USD Million)
Figure 20. Asia-Pacific Companion Diagnostic Consumption Value (2019-2030) & (USD Million)
Figure 21. South America Companion Diagnostic Consumption Value (2019-2030) & (USD Million)
Figure 22. Middle East and Africa Companion Diagnostic Consumption Value (2019-2030) & (USD Million)
Figure 23. Global Companion Diagnostic Revenue Share by Players in 2023
Figure 24. Companion Diagnostic Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2023
Figure 25. Global Top 3 Players Companion Diagnostic Market Share in 2023
Figure 26. Global Top 6 Players Companion Diagnostic Market Share in 2023
Figure 27. Global Companion Diagnostic Consumption Value Share by Type (2019-2024)
Figure 28. Global Companion Diagnostic Market Share Forecast by Type (2025-2030)
Figure 29. Global Companion Diagnostic Consumption Value Share by Application (2019-2024)
Figure 30. Global Companion Diagnostic Market Share Forecast by Application (2025-2030)
Figure 31. North America Companion Diagnostic Consumption Value Market Share by Type (2019-2030)
Figure 32. North America Companion Diagnostic Consumption Value Market Share by Application (2019-2030)
Figure 33. North America Companion Diagnostic Consumption Value Market Share by Country (2019-2030)
Figure 34. United States Companion Diagnostic Consumption Value (2019-2030) & (USD Million)
Figure 35. Canada Companion Diagnostic Consumption Value (2019-2030) & (USD Million)
Figure 36. Mexico Companion Diagnostic Consumption Value (2019-2030) & (USD Million)
Figure 37. Europe Companion Diagnostic Consumption Value Market Share by Type (2019-2030)
Figure 38. Europe Companion Diagnostic Consumption Value Market Share by Application (2019-2030)
Figure 39. Europe Companion Diagnostic Consumption Value Market Share by Country (2019-2030)
Figure 40. Germany Companion Diagnostic Consumption Value (2019-2030) & (USD Million)
Figure 41. France Companion Diagnostic Consumption Value (2019-2030) & (USD Million)
Figure 42. United Kingdom Companion Diagnostic Consumption Value (2019-2030) & (USD Million)
Figure 43. Russia Companion Diagnostic Consumption Value (2019-2030) & (USD Million)
Figure 44. Italy Companion Diagnostic Consumption Value (2019-2030) & (USD Million)
Figure 45. Asia-Pacific Companion Diagnostic Consumption Value Market Share by Type (2019-2030)
Figure 46. Asia-Pacific Companion Diagnostic Consumption Value Market Share by Application (2019-2030)
Figure 47. Asia-Pacific Companion Diagnostic Consumption Value Market Share by Region (2019-2030)
Figure 48. China Companion Diagnostic Consumption Value (2019-2030) & (USD Million)
Figure 49. Japan Companion Diagnostic Consumption Value (2019-2030) & (USD Million)
Figure 50. South Korea Companion Diagnostic Consumption Value (2019-2030) & (USD Million)
Figure 51. India Companion Diagnostic Consumption Value (2019-2030) & (USD Million)
Figure 52. Southeast Asia Companion Diagnostic Consumption Value (2019-2030) & (USD Million)
Figure 53. Australia Companion Diagnostic Consumption Value (2019-2030) & (USD Million)
Figure 54. South America Companion Diagnostic Consumption Value Market Share by Type (2019-2030)
Figure 55. South America Companion Diagnostic Consumption Value Market Share by Application (2019-2030)
Figure 56. South America Companion Diagnostic Consumption Value Market Share by Country (2019-2030)
Figure 57. Brazil Companion Diagnostic Consumption Value (2019-2030) & (USD Million)
Figure 58. Argentina Companion Diagnostic Consumption Value (2019-2030) & (USD Million)
Figure 59. Middle East and Africa Companion Diagnostic Consumption Value Market Share by Type (2019-2030)
Figure 60. Middle East and Africa Companion Diagnostic Consumption Value Market Share by Application (2019-2030)
Figure 61. Middle East and Africa Companion Diagnostic Consumption Value Market Share by Country (2019-2030)
Figure 62. Turkey Companion Diagnostic Consumption Value (2019-2030) & (USD Million)
Figure 63. Saudi Arabia Companion Diagnostic Consumption Value (2019-2030) & (USD Million)
Figure 64. UAE Companion Diagnostic Consumption Value (2019-2030) & (USD Million)
Figure 65. Companion Diagnostic Market Drivers
Figure 66. Companion Diagnostic Market Restraints
Figure 67. Companion Diagnostic Market Trends
Figure 68. Porters Five Forces Analysis
Figure 69. Manufacturing Cost Structure Analysis of Companion Diagnostic in 2023
Figure 70. Manufacturing Process Analysis of Companion Diagnostic
Figure 71. Companion Diagnostic Industrial Chain
Figure 72. Methodology
Figure 73. Research Process and Data Source
Figure 1. Companion Diagnostic Picture
Figure 2. Global Companion Diagnostic Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Companion Diagnostic Consumption Value Market Share by Type in 2023
Figure 4. Immunohistochemistry
Figure 5. Molecular Diagnosis
Figure 6. Global Companion Diagnostic Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 7. Companion Diagnostic Consumption Value Market Share by Application in 2023
Figure 8. Oncology Picture
Figure 9. Cardiovascular Picture
Figure 10. Central Nervous System Picture
Figure 11. Virology Picture
Figure 12. Others Picture
Figure 13. Global Companion Diagnostic Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 14. Global Companion Diagnostic Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 15. Global Market Companion Diagnostic Consumption Value (USD Million) Comparison by Region (2019 & 2023 & 2030)
Figure 16. Global Companion Diagnostic Consumption Value Market Share by Region (2019-2030)
Figure 17. Global Companion Diagnostic Consumption Value Market Share by Region in 2023
Figure 18. North America Companion Diagnostic Consumption Value (2019-2030) & (USD Million)
Figure 19. Europe Companion Diagnostic Consumption Value (2019-2030) & (USD Million)
Figure 20. Asia-Pacific Companion Diagnostic Consumption Value (2019-2030) & (USD Million)
Figure 21. South America Companion Diagnostic Consumption Value (2019-2030) & (USD Million)
Figure 22. Middle East and Africa Companion Diagnostic Consumption Value (2019-2030) & (USD Million)
Figure 23. Global Companion Diagnostic Revenue Share by Players in 2023
Figure 24. Companion Diagnostic Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2023
Figure 25. Global Top 3 Players Companion Diagnostic Market Share in 2023
Figure 26. Global Top 6 Players Companion Diagnostic Market Share in 2023
Figure 27. Global Companion Diagnostic Consumption Value Share by Type (2019-2024)
Figure 28. Global Companion Diagnostic Market Share Forecast by Type (2025-2030)
Figure 29. Global Companion Diagnostic Consumption Value Share by Application (2019-2024)
Figure 30. Global Companion Diagnostic Market Share Forecast by Application (2025-2030)
Figure 31. North America Companion Diagnostic Consumption Value Market Share by Type (2019-2030)
Figure 32. North America Companion Diagnostic Consumption Value Market Share by Application (2019-2030)
Figure 33. North America Companion Diagnostic Consumption Value Market Share by Country (2019-2030)
Figure 34. United States Companion Diagnostic Consumption Value (2019-2030) & (USD Million)
Figure 35. Canada Companion Diagnostic Consumption Value (2019-2030) & (USD Million)
Figure 36. Mexico Companion Diagnostic Consumption Value (2019-2030) & (USD Million)
Figure 37. Europe Companion Diagnostic Consumption Value Market Share by Type (2019-2030)
Figure 38. Europe Companion Diagnostic Consumption Value Market Share by Application (2019-2030)
Figure 39. Europe Companion Diagnostic Consumption Value Market Share by Country (2019-2030)
Figure 40. Germany Companion Diagnostic Consumption Value (2019-2030) & (USD Million)
Figure 41. France Companion Diagnostic Consumption Value (2019-2030) & (USD Million)
Figure 42. United Kingdom Companion Diagnostic Consumption Value (2019-2030) & (USD Million)
Figure 43. Russia Companion Diagnostic Consumption Value (2019-2030) & (USD Million)
Figure 44. Italy Companion Diagnostic Consumption Value (2019-2030) & (USD Million)
Figure 45. Asia-Pacific Companion Diagnostic Consumption Value Market Share by Type (2019-2030)
Figure 46. Asia-Pacific Companion Diagnostic Consumption Value Market Share by Application (2019-2030)
Figure 47. Asia-Pacific Companion Diagnostic Consumption Value Market Share by Region (2019-2030)
Figure 48. China Companion Diagnostic Consumption Value (2019-2030) & (USD Million)
Figure 49. Japan Companion Diagnostic Consumption Value (2019-2030) & (USD Million)
Figure 50. South Korea Companion Diagnostic Consumption Value (2019-2030) & (USD Million)
Figure 51. India Companion Diagnostic Consumption Value (2019-2030) & (USD Million)
Figure 52. Southeast Asia Companion Diagnostic Consumption Value (2019-2030) & (USD Million)
Figure 53. Australia Companion Diagnostic Consumption Value (2019-2030) & (USD Million)
Figure 54. South America Companion Diagnostic Consumption Value Market Share by Type (2019-2030)
Figure 55. South America Companion Diagnostic Consumption Value Market Share by Application (2019-2030)
Figure 56. South America Companion Diagnostic Consumption Value Market Share by Country (2019-2030)
Figure 57. Brazil Companion Diagnostic Consumption Value (2019-2030) & (USD Million)
Figure 58. Argentina Companion Diagnostic Consumption Value (2019-2030) & (USD Million)
Figure 59. Middle East and Africa Companion Diagnostic Consumption Value Market Share by Type (2019-2030)
Figure 60. Middle East and Africa Companion Diagnostic Consumption Value Market Share by Application (2019-2030)
Figure 61. Middle East and Africa Companion Diagnostic Consumption Value Market Share by Country (2019-2030)
Figure 62. Turkey Companion Diagnostic Consumption Value (2019-2030) & (USD Million)
Figure 63. Saudi Arabia Companion Diagnostic Consumption Value (2019-2030) & (USD Million)
Figure 64. UAE Companion Diagnostic Consumption Value (2019-2030) & (USD Million)
Figure 65. Companion Diagnostic Market Drivers
Figure 66. Companion Diagnostic Market Restraints
Figure 67. Companion Diagnostic Market Trends
Figure 68. Porters Five Forces Analysis
Figure 69. Manufacturing Cost Structure Analysis of Companion Diagnostic in 2023
Figure 70. Manufacturing Process Analysis of Companion Diagnostic
Figure 71. Companion Diagnostic Industrial Chain
Figure 72. Methodology
Figure 73. Research Process and Data Source
